Classical and novel anti-cancer immunotherapies (Interferon alpha, Interleukin-2, Immune checkpoint inhibitors, the emerging CAR-T cell therapy) have potential nephrotoxic effects also due to their secondary immune effects [21]. Here, IL2 is linked to cancer.